Zhejiang incorporated 17 kinds of anticancer drugs into medical insurance and carried out special centralized purchase of anticancer drugs for the first time

According to Zhejiang Daily on January 17, to reduce the burden of medication for patients, Zhejiang is the first step! On January 16, the reporter learned from the Zhejiang medical security bureau that at present, Zhejiang Province has included all 17 kinds of anticancer drugs into the reimbursement scope of class B medical insurance drugs in Zhejiang Province, and carried out the special centralized purchase of anticancer drugs for the first time, which is expected to save nearly 900 million yuan every year In recent years, molecular targeted anticancer drugs with definite curative effect have been listed in succession, which has aroused social concern and patients' expectation However, the price of patented and exclusive anticancer drugs is high, and the burden of patients' expenses is heavy In October last year, the State Medical Insurance Bureau issued a notice to include 17 negotiated anti-cancer drugs in the scope of medical insurance B, and simultaneously determined the medical insurance payment standards for these drugs Zhejiang province became one of the first provinces to land the negotiation results in China As of December 14 last year, 17 kinds of anticancer drugs have incurred a total of 52.66 million yuan of drug costs in the whole province A total of 3422 patients enjoy the benefits of policies, and it is estimated that the annual cost savings will be 560 million yuan At present, Zhejiang cancer hospital has 13 kinds of anticancer drugs included in the medical insurance "Take the targeted drug" Teresa "for lung cancer treatment as an example In the past, the price of a box was 51000 yuan and at its own expense At present, the price is 15300 yuan and it is listed in the category B list of medical insurance reimbursement Each box of patients only needs to bear 3000 yuan." Cheng bin, deputy director of medical insurance office of Zhejiang Cancer Hospital, told reporters The reporter learned that of the 17 kinds of anticancer drugs, 9 were transferred from negotiating drugs for serious illness insurance to reimbursement drugs for medical insurance, 8 were directly transferred from self funded drugs to reimbursement drugs for medical insurance, and most of them were paid by medical insurance In addition, for the first time, Zhejiang Province has launched a special centralized procurement of anticancer drugs, with the average price of the winning products dropping by 11.56%.